Scholar Rock

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Scholar Rock sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials 2 currently recruiting 4 completed early-phase tilt upper quartile by trial count

Scholar Rock: 7 sponsored US clinical trials, 2 recruiting.

Scholar Rock sponsors 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 4 completed. 2 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Neuromuscular Manifestations, with 4 trials.

Upper-quartile sponsor footprint

Scholar Rock sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

7 total, page 1 of 1

RECRUITING Phase 1

A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults

NCT07444294
RECRUITING Phase 2

A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy

NCT07047144
ACTIVE NOT RECRUITING Phase 3

Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab

NCT05626855
COMPLETED Phase 2

Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese

NCT06445075
COMPLETED Phase 3

Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam

NCT05156320
COMPLETED Phase 1

SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)

NCT04291079
COMPLETED Phase 2

An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy

NCT03921528

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 3
Phase 3 2

Therapeutic Areas

Neuromuscular Manifestations 4
Spinal Muscular Atrophy Type 2 4
SMA 4
Spinal Muscular Atrophy 4
Spinal Muscular Atrophy Type 3 4
Muscular Atrophy 3
Anti-myostatin 3
Atrophy 3
Muscular Atrophy, Spinal 3
Neuromuscular Diseases 3

What is open in the Scholar Rock pipeline

2 recruiting of 7 indexed (29% open); 4 completed (57%).

Phase mix: 2 late (III/IV) vs 5 early (I/II) (early-phase heavy).

Top condition: Neuromuscular Manifestations (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Scholar Rock: open-pipeline peers nationwide

Peers matched on 7 registered trials and 29% open enrollment, not the therapeutic-area sidebar.

Scholar Rock sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0102030405060 0%10%20%30%40% Total trials Recruiting share Scholar Rock3M4Life Research89bioAbbott Diagnostics DivisionAlabama Physical Therapy & AcupunctureAlloSourceAlnylam PharmaceuticalsAnnovis Bio
Scholar Rock sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Scholar Rock sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 trials (± recruiting share)

Sponsors near 29% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Scholar Rock page

7 registered trials is a research-attention snapshot, not an endorsement of Scholar Rock or any single study.

  • 2 of Scholar Rock's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Neuromuscular Manifestations is the condition Scholar Rock studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Neuromuscular Manifestations trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Scholar Rock pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.